News for CNS Pharmaceuticals, Inc. (CNSP)

– Video webcast now available on-demand HOUSTON, TX / ACCESS Newswire / July 22, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"),

CNS Pharmaceuticals (CNSP) takes center stage at the Virtual Investor

As of 19:50 EDT, trading for CNS Pharmaceuticals (CNSP) has been paused pending significant news. The company has not yet disclosed the nature of the announceme

CNS Pharmaceuticals, recognized by the ticker CNSP, has declared a reverse stock split at a ratio of 1-for-12. This change will take effect starting July 22, 20

CNS Pharmaceuticals (CNSP) announces a 1-for-12 reverse stock split effective July 22, 2025. The company's common stock will continue trading under the

HOUSTON, TX / ACCESS Newswire / July 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in th

HOUSTON, TX / ACCESS Newswire / July 9, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the

CNS Pharmaceuticals (CNSP) CEO John Climaco participates in Virtual Investor CEO Connect segment. Lead program TPI 287 discussed, highlighting its poten

An analyst from Alliance Global Partners, James Molloy, has increased the price target for CNS Pharmaceuticals (CNSP) from $4 to $7 following the company's rece

CNS Pharmaceuticals (CNSP) reported a Q1 2025 net loss of $4.3 million, with R&D expenses of $3.2 million. TPI 287, their lead candidate for glioblastoma, s

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the

China-based Lobo EV Technologies Ltd. (LOBO) is up over 160 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded down 0.06% to 42,556.82 while th...

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.1% on Tuesday. The Dow traded down 0.04% to 42,564.96 while the NASDAQ climbe...

Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:

U.S. stocks traded mixed midway through trading, with the S&P 500 and Nasdaq Composite edging higher on Wednesday. The Dow traded down 0.39% to 44,382.16 while...

U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Wednesday. The Dow traded down 0.33% to 44,408.16 while the NASDAQ...

HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing i

General Motors ends robotaxi development. Bausch & Lomb falls amid report Blackstone may drop out of takeover bid. Microsoft shareholders vote no on bitcoin despite Michael Saylor's pitch.